LEXICON PHARMACEUTICALS, INC.·4

Mar 3, 7:17 AM ET

Crum Brian T 4

4 · LEXICON PHARMACEUTICALS, INC. · Filed Mar 3, 2026

Research Summary

AI-generated summary of this filing

Updated

Lexicon (LXRX) SVP Brian Crum Receives RSUs — 273,006 Converted

What Happened

  • Brian T. Crum, SVP, General Counsel & Secretary of Lexicon Pharmaceuticals (LXRX), had restricted stock units (RSUs) convert/vest into 273,006 shares on February 28, 2026 (reported as derivative exercise/conversion, code M).
  • The company withheld 105,019 of those shares to satisfy tax withholding obligations (transaction coded F) at $1.47 per share, totaling approximately $154,378. After withholding, about 167,987 shares were delivered to Mr. Crum. The conversion entries show N/A for acquisition price because these were RSU conversions, not cash purchases.

Key Details

  • Transaction date: 2026-02-28; Form 4 filed 2026-03-03 (filed within the required two business days).
  • Shares converted (vested): 273,006 total (33,457; 69,386; 170,163 in separate line items).
  • Shares withheld for taxes: 105,019 at $1.47/share = ~$154,378. Net shares received: ~167,987.
  • Footnotes: F1 = each RSU = one share; F2 = company withheld shares to satisfy tax withholding; F3 = RSUs vest 1/3 on Feb 28 in each of three years following grant.
  • Shares owned after the transaction: not specified in the provided Form 4.

Context

  • This was a vesting/conversion of RSUs, not an open-market buy or sale. The withheld shares represent tax withholding (a common administrative step), not a market sale by the insider.
  • Transaction codes: M = exercise/conversion of a derivative (here, RSUs converting to common stock); F = payment/withholding to cover taxes.
  • For retail investors: RSU vesting is routine compensation-related activity and does not necessarily signal a personal buy/sell decision about the company's outlook.

Insider Transaction Report

Form 4
Period: 2026-02-28
Crum Brian T
SVP, General Counsel & Secr.
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-28+33,457363,658 total
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-28+69,386330,201 total
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-28+170,163533,821 total
  • Tax Payment

    Common Stock

    [F2]
    2026-02-28$1.47/sh105,019$154,378428,802 total
  • Exercise/Conversion

    Restricted Stock Units

    [F1][F3]
    2026-02-2869,38669,387 total
    Common Stock (69,386 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F1][F3]
    2026-02-2833,4570 total
    Common Stock (33,457 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F1][F3]
    2026-02-28170,163340,327 total
    Common Stock (170,163 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
  • [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
Signature
/s/ Brian T. Crum|2026-03-03

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT